- Papers in database
- 9
- Primary author
- 4 papers
- Years active
- 2012 – 2021
- Total publications
- 98
- Total citations
- 6,179
- h-index
- 42
- Health outcomes studied
- 1
Research Areas
- Asthma and respiratory diseases
- Allergic Rhinitis and Sensitization
- Gut microbiota and health
- Dermatology and Skin Diseases
- Probiotics and Fermented Foods
Health Outcomes Studied
Papers (9)
- 2021Effect of Lactobacillus rhamnosus Probiotic in Early Pregnancy on Plasma Conjugated Bile Acids in a Randomised Controlled Trial10.3390/nu13010209
- 2019Food 4 Health - He Oranga Kai: Assessing the efficacy, acceptability and economic implications of Lactobacillus rhamnosus HN001 and β-glucan to improve glycated haemoglobin, metabolic health, and general well-being in adults with pre-diabetes: study protocol for a 2 × 2 factorial design, parallel group, placebo-controlled randomized controlled trial, with embedded qualitative study and economic analysis.10.1186/s13063-019-3553-7
- 2019Eczema-protective probiotic alters infant gut microbiome functional capacity but not composition: sub-sample analysis from a RCT.10.3920/bm2017.0191
- 2018Effect of early probiotic supplementation on childhood cognition, behaviour and mood a randomised, placebo-controlled trial.10.1111/apa.14590
- 2018Primary authorMaternal supplementation alone with Lactobacillus rhamnosus HN001 during pregnancy and breastfeeding does not reduce infant eczema10.1111/pai.12874
- 2018Primary authorEffects of Lactobacillus rhamnosus HN001 in early life on the cumulative prevalence of allergic disease to 11 years10.1111/pai.12982
- 2017Primary authorEarly pregnancy probiotic supplementation with Lactobacillus rhamnosus HN001 may reduce the prevalence of gestational diabetes mellitus: a randomised controlled trial10.1017/S0007114517000289
- 2017Effect of Lactobacillus rhamnosus HN001 in Pregnancy on Postpartum Symptoms of Depression and Anxiety: A Randomised Double-blind Placebo-controlled Trial10.1016/j.ebiom.2017.09.013
- 2012Primary authorA protective effect of Lactobacillus rhamnosus HN001 against eczema in the first 2 years of life persists to age 4 years10.1111/j.1365-2222.2012.03975.x